nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—GABRR3—retina—malignant glioma	0.0137	0.0375	CbGeAlD
Estazolam—Hypokinesia—Carmustine—malignant glioma	0.012	0.0229	CcSEcCtD
Estazolam—GABRR2—retina—malignant glioma	0.0119	0.0325	CbGeAlD
Estazolam—GABRR1—retina—malignant glioma	0.0114	0.0313	CbGeAlD
Estazolam—Apathy—Temozolomide—malignant glioma	0.011	0.0209	CcSEcCtD
Estazolam—Flat affect—Temozolomide—malignant glioma	0.0109	0.0208	CcSEcCtD
Estazolam—Stupor—Carmustine—malignant glioma	0.0109	0.0207	CcSEcCtD
Estazolam—Scotoma—Carmustine—malignant glioma	0.0107	0.0204	CcSEcCtD
Estazolam—Scotoma—Temozolomide—malignant glioma	0.0103	0.0197	CcSEcCtD
Estazolam—GABRD—telencephalon—malignant glioma	0.00914	0.025	CbGeAlD
Estazolam—Thinking abnormal—Carmustine—malignant glioma	0.00888	0.0169	CcSEcCtD
Estazolam—GABRG1—telencephalon—malignant glioma	0.0088	0.0241	CbGeAlD
Estazolam—GABRB1—telencephalon—malignant glioma	0.00853	0.0233	CbGeAlD
Estazolam—GABRA5—telencephalon—malignant glioma	0.00848	0.0232	CbGeAlD
Estazolam—Coordination abnormal—Carmustine—malignant glioma	0.00828	0.0158	CcSEcCtD
Estazolam—Hearing impaired—Temozolomide—malignant glioma	0.00825	0.0157	CcSEcCtD
Estazolam—Neck pain—Carmustine—malignant glioma	0.00823	0.0157	CcSEcCtD
Estazolam—Coordination abnormal—Temozolomide—malignant glioma	0.008	0.0152	CcSEcCtD
Estazolam—Urinary incontinence—Carmustine—malignant glioma	0.00785	0.0149	CcSEcCtD
Estazolam—Depressed level of consciousness—Carmustine—malignant glioma	0.00785	0.0149	CcSEcCtD
Estazolam—Urinary incontinence—Temozolomide—malignant glioma	0.00759	0.0144	CcSEcCtD
Estazolam—Depressed level of consciousness—Temozolomide—malignant glioma	0.00759	0.0144	CcSEcCtD
Estazolam—GABRB2—brainstem—malignant glioma	0.00726	0.0199	CbGeAlD
Estazolam—GABRD—medulla oblongata—malignant glioma	0.00718	0.0196	CbGeAlD
Estazolam—Abnormal vision—Carmustine—malignant glioma	0.00709	0.0135	CcSEcCtD
Estazolam—Mental disability—Carmustine—malignant glioma	0.00705	0.0134	CcSEcCtD
Estazolam—GABRG1—medulla oblongata—malignant glioma	0.00691	0.0189	CbGeAlD
Estazolam—Abnormal vision—Temozolomide—malignant glioma	0.00685	0.013	CcSEcCtD
Estazolam—Mental disability—Temozolomide—malignant glioma	0.00682	0.013	CcSEcCtD
Estazolam—GABRB1—medulla oblongata—malignant glioma	0.0067	0.0183	CbGeAlD
Estazolam—Ear pain—Temozolomide—malignant glioma	0.00668	0.0127	CcSEcCtD
Estazolam—GABRA2—brainstem—malignant glioma	0.00663	0.0181	CbGeAlD
Estazolam—GABRD—midbrain—malignant glioma	0.00656	0.018	CbGeAlD
Estazolam—Eye pain—Carmustine—malignant glioma	0.00654	0.0124	CcSEcCtD
Estazolam—GABRB2—telencephalon—malignant glioma	0.00644	0.0176	CbGeAlD
Estazolam—GABRG2—telencephalon—malignant glioma	0.00644	0.0176	CbGeAlD
Estazolam—GABRA1—brainstem—malignant glioma	0.00641	0.0175	CbGeAlD
Estazolam—Vascular purpura—Temozolomide—malignant glioma	0.00637	0.0121	CcSEcCtD
Estazolam—GABRG1—midbrain—malignant glioma	0.00632	0.0173	CbGeAlD
Estazolam—Eye pain—Temozolomide—malignant glioma	0.00632	0.012	CcSEcCtD
Estazolam—Amnesia—Carmustine—malignant glioma	0.00628	0.012	CcSEcCtD
Estazolam—GABRG3—central nervous system—malignant glioma	0.00627	0.0172	CbGeAlD
Estazolam—GABRG1—spinal cord—malignant glioma	0.00616	0.0169	CbGeAlD
Estazolam—GABRB1—midbrain—malignant glioma	0.00613	0.0168	CbGeAlD
Estazolam—GABRR2—cerebellum—malignant glioma	0.00607	0.0166	CbGeAlD
Estazolam—Amnesia—Temozolomide—malignant glioma	0.00607	0.0116	CcSEcCtD
Estazolam—Thirst—Temozolomide—malignant glioma	0.00599	0.0114	CcSEcCtD
Estazolam—GABRR1—central nervous system—malignant glioma	0.00598	0.0164	CbGeAlD
Estazolam—GABRB1—spinal cord—malignant glioma	0.00598	0.0164	CbGeAlD
Estazolam—Purpura—Temozolomide—malignant glioma	0.00592	0.0113	CcSEcCtD
Estazolam—Diplopia—Carmustine—malignant glioma	0.0059	0.0112	CcSEcCtD
Estazolam—GABRA2—telencephalon—malignant glioma	0.00588	0.0161	CbGeAlD
Estazolam—Diplopia—Temozolomide—malignant glioma	0.0057	0.0109	CcSEcCtD
Estazolam—GABRA1—telencephalon—malignant glioma	0.00569	0.0156	CbGeAlD
Estazolam—Affect lability—Temozolomide—malignant glioma	0.00561	0.0107	CcSEcCtD
Estazolam—Ataxia—Carmustine—malignant glioma	0.00555	0.0106	CcSEcCtD
Estazolam—Mood swings—Temozolomide—malignant glioma	0.0054	0.0103	CcSEcCtD
Estazolam—Ataxia—Temozolomide—malignant glioma	0.00536	0.0102	CcSEcCtD
Estazolam—Dry skin—Temozolomide—malignant glioma	0.00523	0.00995	CcSEcCtD
Estazolam—GABRD—central nervous system—malignant glioma	0.00519	0.0142	CbGeAlD
Estazolam—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00513	0.00978	CcSEcCtD
Estazolam—GABRD—cerebellum—malignant glioma	0.00508	0.0139	CbGeAlD
Estazolam—GABRB2—medulla oblongata—malignant glioma	0.00506	0.0138	CbGeAlD
Estazolam—GABRG2—medulla oblongata—malignant glioma	0.00506	0.0138	CbGeAlD
Estazolam—GABRG1—central nervous system—malignant glioma	0.005	0.0137	CbGeAlD
Estazolam—GABRG3—brain—malignant glioma	0.00498	0.0136	CbGeAlD
Estazolam—GABRB3—telencephalon—malignant glioma	0.00494	0.0135	CbGeAlD
Estazolam—GABRG1—cerebellum—malignant glioma	0.00489	0.0134	CbGeAlD
Estazolam—GABRB1—central nervous system—malignant glioma	0.00485	0.0133	CbGeAlD
Estazolam—GABRA5—central nervous system—malignant glioma	0.00482	0.0132	CbGeAlD
Estazolam—GABRR1—brain—malignant glioma	0.00475	0.013	CbGeAlD
Estazolam—GABRB1—cerebellum—malignant glioma	0.00474	0.013	CbGeAlD
Estazolam—GABRG2—midbrain—malignant glioma	0.00462	0.0127	CbGeAlD
Estazolam—GABRB2—midbrain—malignant glioma	0.00462	0.0127	CbGeAlD
Estazolam—Pollakiuria—Temozolomide—malignant glioma	0.00455	0.00867	CcSEcCtD
Estazolam—Depression—Carmustine—malignant glioma	0.00453	0.00863	CcSEcCtD
Estazolam—GABRB2—spinal cord—malignant glioma	0.00451	0.0123	CbGeAlD
Estazolam—GABRG2—spinal cord—malignant glioma	0.00451	0.0123	CbGeAlD
Estazolam—Photosensitivity reaction—Temozolomide—malignant glioma	0.0045	0.00857	CcSEcCtD
Estazolam—GABRA3—central nervous system—malignant glioma	0.00449	0.0123	CbGeAlD
Estazolam—Weight increased—Temozolomide—malignant glioma	0.00449	0.00854	CcSEcCtD
Estazolam—GABRA1—medulla oblongata—malignant glioma	0.00447	0.0122	CbGeAlD
Estazolam—Weight decreased—Temozolomide—malignant glioma	0.00446	0.00849	CcSEcCtD
Estazolam—Neuropathy peripheral—Carmustine—malignant glioma	0.00446	0.00849	CcSEcCtD
Estazolam—Depression—Temozolomide—malignant glioma	0.00438	0.00834	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00436	0.00829	CcSEcCtD
Estazolam—Neuropathy peripheral—Temozolomide—malignant glioma	0.00431	0.0082	CcSEcCtD
Estazolam—GABRD—brain—malignant glioma	0.00412	0.0113	CbGeAlD
Estazolam—Sinusitis—Temozolomide—malignant glioma	0.00412	0.00785	CcSEcCtD
Estazolam—GABRA1—midbrain—malignant glioma	0.00408	0.0112	CbGeAlD
Estazolam—Hallucination—Carmustine—malignant glioma	0.00406	0.00773	CcSEcCtD
Estazolam—GABRA1—spinal cord—malignant glioma	0.00398	0.0109	CbGeAlD
Estazolam—GABRG1—brain—malignant glioma	0.00397	0.0109	CbGeAlD
Estazolam—Visual impairment—Carmustine—malignant glioma	0.00393	0.00749	CcSEcCtD
Estazolam—Hallucination—Temozolomide—malignant glioma	0.00392	0.00747	CcSEcCtD
Estazolam—Pharyngitis—Temozolomide—malignant glioma	0.00392	0.00745	CcSEcCtD
Estazolam—GABRB3—medulla oblongata—malignant glioma	0.00389	0.0106	CbGeAlD
Estazolam—GABRB1—brain—malignant glioma	0.00385	0.0105	CbGeAlD
Estazolam—GABRA5—brain—malignant glioma	0.00383	0.0105	CbGeAlD
Estazolam—Visual impairment—Temozolomide—malignant glioma	0.0038	0.00724	CcSEcCtD
Estazolam—Flushing—Carmustine—malignant glioma	0.00379	0.00721	CcSEcCtD
Estazolam—Mazindol—SLC6A3—malignant glioma	0.00377	0.185	CrCbGaD
Estazolam—Erythema multiforme—Temozolomide—malignant glioma	0.00373	0.0071	CcSEcCtD
Estazolam—Tinnitus—Temozolomide—malignant glioma	0.00368	0.007	CcSEcCtD
Estazolam—Flushing—Temozolomide—malignant glioma	0.00366	0.00697	CcSEcCtD
Estazolam—GABRB2—central nervous system—malignant glioma	0.00366	0.01	CbGeAlD
Estazolam—GABRG2—central nervous system—malignant glioma	0.00366	0.01	CbGeAlD
Estazolam—Arrhythmia—Carmustine—malignant glioma	0.00365	0.00694	CcSEcCtD
Estazolam—GABRG2—cerebellum—malignant glioma	0.00358	0.00979	CbGeAlD
Estazolam—GABRB2—cerebellum—malignant glioma	0.00358	0.00979	CbGeAlD
Estazolam—GABRA3—brain—malignant glioma	0.00356	0.00975	CbGeAlD
Estazolam—Malnutrition—Carmustine—malignant glioma	0.00355	0.00677	CcSEcCtD
Estazolam—GABRB3—midbrain—malignant glioma	0.00355	0.00972	CbGeAlD
Estazolam—Chills—Temozolomide—malignant glioma	0.00354	0.00674	CcSEcCtD
Estazolam—GABRB3—spinal cord—malignant glioma	0.00346	0.00948	CbGeAlD
Estazolam—Back pain—Carmustine—malignant glioma	0.00344	0.00654	CcSEcCtD
Estazolam—Malnutrition—Temozolomide—malignant glioma	0.00343	0.00654	CcSEcCtD
Estazolam—GABRA2—central nervous system—malignant glioma	0.00334	0.00915	CbGeAlD
Estazolam—Tremor—Carmustine—malignant glioma	0.00333	0.00634	CcSEcCtD
Estazolam—Back pain—Temozolomide—malignant glioma	0.00332	0.00632	CcSEcCtD
Estazolam—GABRE—central nervous system—malignant glioma	0.00332	0.00907	CbGeAlD
Estazolam—GABRA2—cerebellum—malignant glioma	0.00327	0.00894	CbGeAlD
Estazolam—Agitation—Carmustine—malignant glioma	0.00327	0.00622	CcSEcCtD
Estazolam—GABRA1—central nervous system—malignant glioma	0.00323	0.00884	CbGeAlD
Estazolam—Tremor—Temozolomide—malignant glioma	0.00322	0.00613	CcSEcCtD
Estazolam—Ill-defined disorder—Temozolomide—malignant glioma	0.00319	0.00607	CcSEcCtD
Estazolam—Leukopenia—Carmustine—malignant glioma	0.00318	0.00606	CcSEcCtD
Estazolam—GABRA1—cerebellum—malignant glioma	0.00316	0.00864	CbGeAlD
Estazolam—Agitation—Temozolomide—malignant glioma	0.00316	0.00601	CcSEcCtD
Estazolam—Clobazam—CYP2C18—malignant glioma	0.00313	0.154	CrCbGaD
Estazolam—Malaise—Temozolomide—malignant glioma	0.0031	0.0059	CcSEcCtD
Estazolam—Convulsion—Carmustine—malignant glioma	0.00308	0.00586	CcSEcCtD
Estazolam—Leukopenia—Temozolomide—malignant glioma	0.00307	0.00585	CcSEcCtD
Estazolam—Palpitations—Temozolomide—malignant glioma	0.00303	0.00578	CcSEcCtD
Estazolam—Chest pain—Carmustine—malignant glioma	0.00303	0.00576	CcSEcCtD
Estazolam—Myalgia—Carmustine—malignant glioma	0.00303	0.00576	CcSEcCtD
Estazolam—Anxiety—Carmustine—malignant glioma	0.00301	0.00574	CcSEcCtD
Estazolam—Cough—Temozolomide—malignant glioma	0.003	0.00571	CcSEcCtD
Estazolam—Convulsion—Temozolomide—malignant glioma	0.00298	0.00566	CcSEcCtD
Estazolam—Confusional state—Carmustine—malignant glioma	0.00292	0.00557	CcSEcCtD
Estazolam—Arthralgia—Temozolomide—malignant glioma	0.00292	0.00557	CcSEcCtD
Estazolam—Myalgia—Temozolomide—malignant glioma	0.00292	0.00557	CcSEcCtD
Estazolam—Anxiety—Temozolomide—malignant glioma	0.00291	0.00555	CcSEcCtD
Estazolam—GABRG2—brain—malignant glioma	0.00291	0.00795	CbGeAlD
Estazolam—GABRB2—brain—malignant glioma	0.00291	0.00795	CbGeAlD
Estazolam—Oedema—Carmustine—malignant glioma	0.0029	0.00552	CcSEcCtD
Estazolam—Discomfort—Temozolomide—malignant glioma	0.00289	0.0055	CcSEcCtD
Estazolam—Dry mouth—Temozolomide—malignant glioma	0.00286	0.00544	CcSEcCtD
Estazolam—Confusional state—Temozolomide—malignant glioma	0.00283	0.00538	CcSEcCtD
Estazolam—GABRB3—central nervous system—malignant glioma	0.00281	0.00769	CbGeAlD
Estazolam—Oedema—Temozolomide—malignant glioma	0.0028	0.00534	CcSEcCtD
Estazolam—GABRB3—cerebellum—malignant glioma	0.00275	0.00752	CbGeAlD
Estazolam—Hyperhidrosis—Temozolomide—malignant glioma	0.00271	0.00516	CcSEcCtD
Estazolam—GABRA2—brain—malignant glioma	0.00265	0.00726	CbGeAlD
Estazolam—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00264	0.00503	CcSEcCtD
Estazolam—GABRE—brain—malignant glioma	0.00263	0.0072	CbGeAlD
Estazolam—Paraesthesia—Carmustine—malignant glioma	0.0026	0.00496	CcSEcCtD
Estazolam—Dyspnoea—Carmustine—malignant glioma	0.00259	0.00492	CcSEcCtD
Estazolam—Somnolence—Carmustine—malignant glioma	0.00258	0.00491	CcSEcCtD
Estazolam—GABRA1—brain—malignant glioma	0.00257	0.00702	CbGeAlD
Estazolam—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00255	0.00486	CcSEcCtD
Estazolam—Decreased appetite—Carmustine—malignant glioma	0.00252	0.0048	CcSEcCtD
Estazolam—Paraesthesia—Temozolomide—malignant glioma	0.00252	0.00479	CcSEcCtD
Estazolam—Dyspnoea—Temozolomide—malignant glioma	0.0025	0.00476	CcSEcCtD
Estazolam—Somnolence—Temozolomide—malignant glioma	0.00249	0.00474	CcSEcCtD
Estazolam—Pain—Carmustine—malignant glioma	0.00248	0.00472	CcSEcCtD
Estazolam—Constipation—Carmustine—malignant glioma	0.00248	0.00472	CcSEcCtD
Estazolam—Dyspepsia—Temozolomide—malignant glioma	0.00247	0.0047	CcSEcCtD
Estazolam—Decreased appetite—Temozolomide—malignant glioma	0.00244	0.00464	CcSEcCtD
Estazolam—Pain—Temozolomide—malignant glioma	0.0024	0.00456	CcSEcCtD
Estazolam—Constipation—Temozolomide—malignant glioma	0.0024	0.00456	CcSEcCtD
Estazolam—Feeling abnormal—Carmustine—malignant glioma	0.00239	0.00455	CcSEcCtD
Estazolam—Gastrointestinal pain—Carmustine—malignant glioma	0.00237	0.00452	CcSEcCtD
Estazolam—Clobazam—CYP2B6—malignant glioma	0.00232	0.114	CrCbGaD
Estazolam—Feeling abnormal—Temozolomide—malignant glioma	0.00231	0.0044	CcSEcCtD
Estazolam—Abdominal pain—Carmustine—malignant glioma	0.00229	0.00437	CcSEcCtD
Estazolam—Body temperature increased—Carmustine—malignant glioma	0.00229	0.00437	CcSEcCtD
Estazolam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00229	0.00436	CcSEcCtD
Estazolam—GABRB3—brain—malignant glioma	0.00223	0.0061	CbGeAlD
Estazolam—Urticaria—Temozolomide—malignant glioma	0.00223	0.00424	CcSEcCtD
Estazolam—Abdominal pain—Temozolomide—malignant glioma	0.00222	0.00422	CcSEcCtD
Estazolam—Body temperature increased—Temozolomide—malignant glioma	0.00222	0.00422	CcSEcCtD
Estazolam—Hypersensitivity—Carmustine—malignant glioma	0.00214	0.00407	CcSEcCtD
Estazolam—Flunitrazepam—CYP2B6—malignant glioma	0.00213	0.104	CrCbGaD
Estazolam—Asthenia—Carmustine—malignant glioma	0.00208	0.00396	CcSEcCtD
Estazolam—Hypersensitivity—Temozolomide—malignant glioma	0.00206	0.00393	CcSEcCtD
Estazolam—Asthenia—Temozolomide—malignant glioma	0.00201	0.00383	CcSEcCtD
Estazolam—Pruritus—Temozolomide—malignant glioma	0.00198	0.00378	CcSEcCtD
Estazolam—Dizziness—Carmustine—malignant glioma	0.00192	0.00365	CcSEcCtD
Estazolam—Dizziness—Temozolomide—malignant glioma	0.00185	0.00353	CcSEcCtD
Estazolam—Vomiting—Carmustine—malignant glioma	0.00184	0.00351	CcSEcCtD
Estazolam—Rash—Carmustine—malignant glioma	0.00183	0.00348	CcSEcCtD
Estazolam—Dermatitis—Carmustine—malignant glioma	0.00183	0.00348	CcSEcCtD
Estazolam—Diazepam—CYP2C18—malignant glioma	0.00183	0.0897	CrCbGaD
Estazolam—Headache—Carmustine—malignant glioma	0.00182	0.00346	CcSEcCtD
Estazolam—Vomiting—Temozolomide—malignant glioma	0.00178	0.00339	CcSEcCtD
Estazolam—Rash—Temozolomide—malignant glioma	0.00177	0.00336	CcSEcCtD
Estazolam—Dermatitis—Temozolomide—malignant glioma	0.00177	0.00336	CcSEcCtD
Estazolam—Headache—Temozolomide—malignant glioma	0.00176	0.00334	CcSEcCtD
Estazolam—Amoxapine—SLC6A3—malignant glioma	0.00174	0.0854	CrCbGaD
Estazolam—Nausea—Carmustine—malignant glioma	0.00172	0.00328	CcSEcCtD
Estazolam—Nausea—Temozolomide—malignant glioma	0.00166	0.00317	CcSEcCtD
Estazolam—Temazepam—CYP2B6—malignant glioma	0.00163	0.0801	CrCbGaD
Estazolam—Midazolam—CYP2B6—malignant glioma	0.00158	0.0777	CrCbGaD
Estazolam—CYP3A4—central nervous system—malignant glioma	0.00144	0.00394	CbGeAlD
Estazolam—Diazepam—CYP2B6—malignant glioma	0.00136	0.0666	CrCbGaD
Estazolam—Diazepam—PTGS1—malignant glioma	0.000892	0.0438	CrCbGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00025	0.00281	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000249	0.0028	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—BCHE—malignant glioma	0.000248	0.00279	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000247	0.00278	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000245	0.00275	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—BCHE—malignant glioma	0.000245	0.00275	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000243	0.00273	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000243	0.00273	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000241	0.00271	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000239	0.00269	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000236	0.00266	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000236	0.00265	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000235	0.00264	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000235	0.00264	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000234	0.00264	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000234	0.00263	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—SLC6A3—malignant glioma	0.000234	0.00263	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000232	0.00261	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—SLC6A3—malignant glioma	0.00023	0.00259	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—APOD—malignant glioma	0.00023	0.00258	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000228	0.00256	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000226	0.00254	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—APOD—malignant glioma	0.000225	0.00253	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—SPP1—malignant glioma	0.000225	0.00253	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000224	0.00252	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000224	0.00252	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000223	0.00251	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000222	0.0025	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000222	0.0025	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000221	0.00249	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00022	0.00248	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—APOD—malignant glioma	0.00022	0.00247	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000218	0.00245	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000217	0.00244	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000216	0.00243	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000211	0.00237	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BCHE—malignant glioma	0.000209	0.00235	CbGpPWpGaD
Estazolam—GABRR1—Ion channel transport—RAF1—malignant glioma	0.000208	0.00234	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000205	0.00231	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000203	0.00229	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—BCHE—malignant glioma	0.000203	0.00228	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000201	0.00226	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BCHE—malignant glioma	0.0002	0.00224	CbGpPWpGaD
Estazolam—GABRR2—Ion channel transport—RAF1—malignant glioma	0.000199	0.00223	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—SLC6A3—malignant glioma	0.000197	0.00221	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BCHE—malignant glioma	0.000196	0.0022	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000196	0.0022	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BCHE—malignant glioma	0.000195	0.00219	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000194	0.00218	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BCHE—malignant glioma	0.000191	0.00215	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—SLC6A3—malignant glioma	0.000191	0.00215	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000189	0.00212	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—SLC6A3—malignant glioma	0.000188	0.00211	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—BAD—malignant glioma	0.000185	0.00208	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000185	0.00208	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000184	0.00207	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—SLC6A3—malignant glioma	0.000184	0.00207	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000184	0.00207	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—SLC6A3—malignant glioma	0.000183	0.00206	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000183	0.00206	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000182	0.00204	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000181	0.00204	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00018	0.00202	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—SLC6A3—malignant glioma	0.00018	0.00202	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—APC—malignant glioma	0.00018	0.00202	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000177	0.00199	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000176	0.00198	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—PTPN11—malignant glioma	0.000176	0.00198	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000176	0.00198	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000174	0.00196	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000174	0.00195	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000173	0.00194	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000169	0.00191	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000169	0.0019	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000168	0.00189	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000168	0.00189	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000168	0.00189	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BCHE—malignant glioma	0.000167	0.00188	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000165	0.00186	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000164	0.00184	CbGpPWpGaD
Estazolam—GABRG3—Ion channel transport—RAF1—malignant glioma	0.000164	0.00184	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000163	0.00183	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—BRAF—malignant glioma	0.000161	0.00181	CbGpPWpGaD
Estazolam—GABRB1—Ion channel transport—RAF1—malignant glioma	0.000161	0.00181	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00016	0.0018	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00016	0.0018	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000157	0.00177	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000155	0.00175	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000155	0.00174	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000154	0.00173	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—BRAF—malignant glioma	0.000154	0.00173	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000153	0.00171	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000151	0.0017	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00015	0.00169	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000148	0.00167	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000148	0.00167	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000148	0.00166	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000146	0.00164	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000146	0.00164	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000145	0.00163	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000145	0.00163	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000144	0.00162	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000144	0.00162	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000142	0.0016	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000142	0.00159	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000141	0.00159	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—RAF1—malignant glioma	0.000141	0.00158	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000139	0.00157	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000139	0.00156	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000138	0.00155	CbGpPWpGaD
Estazolam—GABRB2—Ion channel transport—RAF1—malignant glioma	0.000138	0.00155	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000137	0.00154	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000136	0.00153	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000135	0.00152	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—MDM2—malignant glioma	0.000135	0.00152	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—RAF1—malignant glioma	0.000135	0.00152	CbGpPWpGaD
Estazolam—GABRA5—Ion channel transport—RAF1—malignant glioma	0.000134	0.0015	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000133	0.00149	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000132	0.00148	CbGpPWpGaD
Estazolam—GABRA3—Ion channel transport—RAF1—malignant glioma	0.000131	0.00148	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000131	0.00147	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00013	0.00146	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00013	0.00146	CbGpPWpGaD
Estazolam—GABRA2—Ion channel transport—RAF1—malignant glioma	0.000129	0.00145	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—MDM2—malignant glioma	0.000129	0.00145	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—RAF1—malignant glioma	0.000129	0.00145	CbGpPWpGaD
Estazolam—GABRB3—Ion channel transport—RAF1—malignant glioma	0.000128	0.00144	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000127	0.00143	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—BRAF—malignant glioma	0.000127	0.00143	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CASP3—malignant glioma	0.000127	0.00142	CbGpPWpGaD
Estazolam—GABRG2—Ion channel transport—RAF1—malignant glioma	0.000126	0.00142	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000126	0.00141	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—BRAF—malignant glioma	0.000125	0.0014	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000125	0.0014	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000124	0.0014	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000124	0.00139	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000124	0.00139	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000123	0.00138	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000121	0.00136	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000117	0.00132	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000117	0.00131	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000116	0.00131	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000115	0.0013	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000113	0.00127	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000113	0.00127	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000113	0.00127	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000113	0.00127	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000111	0.00125	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000111	0.00125	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000111	0.00125	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000111	0.00125	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000111	0.00124	CbGpPWpGaD
Estazolam—GABRA1—Ion channel transport—RAF1—malignant glioma	0.00011	0.00124	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000109	0.00123	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000109	0.00123	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000109	0.00122	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000108	0.00122	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000108	0.00121	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000108	0.00121	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000107	0.0012	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BRAF—malignant glioma	0.000107	0.0012	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000106	0.0012	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000106	0.0012	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000106	0.0012	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.000106	0.0012	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MDM2—malignant glioma	0.000106	0.00119	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000106	0.00119	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—RAF1—malignant glioma	0.000106	0.00119	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000106	0.00119	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MDM2—malignant glioma	0.000105	0.00118	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—RAF1—malignant glioma	0.000104	0.00117	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000104	0.00117	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—BRAF—malignant glioma	0.000104	0.00117	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000103	0.00116	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000103	0.00115	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000102	0.00115	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000102	0.00115	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BRAF—malignant glioma	0.000102	0.00114	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000102	0.00114	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000101	0.00113	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BRAF—malignant glioma	0.0001	0.00113	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BRAF—malignant glioma	9.94e-05	0.00112	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.91e-05	0.00111	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.85e-05	0.00111	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BRAF—malignant glioma	9.76e-05	0.0011	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.67e-05	0.00109	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	9.67e-05	0.00109	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	9.34e-05	0.00105	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	9.33e-05	0.00105	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	9.3e-05	0.00105	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—MDM2—malignant glioma	8.94e-05	0.00101	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—RAF1—malignant glioma	8.91e-05	0.001	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.88e-05	0.000998	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTT1—malignant glioma	8.73e-05	0.000982	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MDM2—malignant glioma	8.69e-05	0.000977	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—RAF1—malignant glioma	8.66e-05	0.000973	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	8.64e-05	0.000972	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BRAF—malignant glioma	8.53e-05	0.000959	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MDM2—malignant glioma	8.53e-05	0.000959	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—RAF1—malignant glioma	8.5e-05	0.000956	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.45e-05	0.00095	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—MDM2—malignant glioma	8.38e-05	0.000943	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—RAF1—malignant glioma	8.35e-05	0.000939	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MDM2—malignant glioma	8.33e-05	0.000936	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—RAF1—malignant glioma	8.3e-05	0.000933	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	8.18e-05	0.00092	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MDM2—malignant glioma	8.18e-05	0.00092	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—RAF1—malignant glioma	8.15e-05	0.000916	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	7.41e-05	0.000833	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.25e-05	0.000815	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MDM2—malignant glioma	7.15e-05	0.000804	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—RAF1—malignant glioma	7.12e-05	0.000801	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—RAF1—malignant glioma	6.91e-05	0.000777	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	6.85e-05	0.00077	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—RTEL1—malignant glioma	6.12e-05	0.000688	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	6.05e-05	0.000681	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	5.97e-05	0.000671	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	5.69e-05	0.00064	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.61e-05	0.00063	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.79e-05	0.000539	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	4.65e-05	0.000523	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	4.57e-05	0.000514	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.49e-05	0.000505	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	4.46e-05	0.000502	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.38e-05	0.000493	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.83e-05	0.000431	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—COX8A—malignant glioma	3.52e-05	0.000395	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ASMT—malignant glioma	2.99e-05	0.000336	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—BCAN—malignant glioma	2.81e-05	0.000316	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—IDH2—malignant glioma	2.27e-05	0.000255	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.13e-05	0.000239	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—IDH1—malignant glioma	1.95e-05	0.000219	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SPHK1—malignant glioma	1.88e-05	0.000212	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.85e-05	0.000208	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTT1—malignant glioma	1.49e-05	0.000168	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS1—malignant glioma	1.4e-05	0.000157	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—BCHE—malignant glioma	1.3e-05	0.000146	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.29e-05	0.000144	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTP1—malignant glioma	1.04e-05	0.000116	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CAT—malignant glioma	1.01e-05	0.000113	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOR1—malignant glioma	9.51e-06	0.000107	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CAV1—malignant glioma	7.75e-06	8.72e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.06e-06	7.94e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPARG—malignant glioma	6.82e-06	7.67e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.21e-06	6.98e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.41e-06	6.09e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS2—malignant glioma	5.36e-06	6.03e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTEN—malignant glioma	4.68e-06	5.26e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.3e-06	3.71e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—malignant glioma	2.7e-06	3.03e-05	CbGpPWpGaD
